France vs Singapore: Number of isolates tested for ceftriaxone
France
200
in 2020
Singapore
232
in 2020
France rank
15th
Singapore rank
13th
Number of isolates tested for ceftriaxone over time
- France
- Singapore
How they compare
Singapore currently reports 232 against 200 in France, a difference of 32.
That makes Singapore's figure about 1.2 times France's.
The two have swapped places 4 times across 10 shared years of data; in 2009 it was Singapore ahead.
France ranks 15th and Singapore ranks 13th of 52 countries.
Across the 3 decades both report, France averaged higher in 1 and Singapore in 2.
Head to head by decade
| Decade | France | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 104 | 160 | 56 | Singapore |
| 2010s | 108.12 | 100.25 | 7.88 | France |
| 2020s | 200 | 232 | 32 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, France or Singapore?
- Singapore, at 232 against 200 in France as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between France and Singapore?
- 32, with Singapore ahead.
- How many years of comparable data are there for France and Singapore?
- 10 years are reported by both, from 2009 to 2020.
- How do France and Singapore rank globally for number of isolates tested for ceftriaxone?
- France ranks 15th and Singapore ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.